About Levin Formulations Private Limited
Data last updated:
Levin Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2019PTC133420. Its GSTIN is 36AADCL9559K1ZU (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kunchala Srinivasarao and Anasuya Kunchala.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 11 – 13 – 1274 Plot No.33 Road No.3 Vasavi Colony Hyderabad, Telangana, India – 500102.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.36 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹67.94 Lakh (net margin -28.7%) and EBITDA of -₹44.05 Lakh (EBITDA margin -18.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 38% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Levin Formulations.
For more details, the company can be reached via its website levinformulations.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH No. 11 – 13 – 1274 Plot No.33 Road No.3 Vasavi Colony Hyderabad, Telangana, India – 500102
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Levin Formulations Private Limited
The main business activity of Levin Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Levin Formulations Private Limited FY 2025 filings available
Levin Formulations Private Limited reported revenue of ₹2.36 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Levin Formulations Private Limited
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 396% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Levin Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹44.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹67.94 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Levin Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -28.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Levin Formulations are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Levin Formulations Private Limited
Levin Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inovin Pharmaceuticals Private Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Manimajra, Chandigarh, India |
| Abhiru Industries Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Hyderabad, Telangana, India |
| Supraceuticals Private Limited | ₹2.37 Cr (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Apricot Labs Private Limited | ₹2.37 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Hyderabad, Telangana, India |
| Bull Pharmaceuticals Private Limited | ₹2.37 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Telangana, India |
| Levin Formulations Private Limited this company | ₹2.36 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| Saboori Pharma Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Telangana, India |
| Wagnerhuber Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Chandigarh, India |
| Zupisure Formulations Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Mumbai, Maharashtra, India |
| Famy Life Sciences Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Arka Vital Science Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Levin Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Levin Formulations Private Limited
Levin Formulations Private Limited is audited by U R N & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| U R N & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Levin Formulations Private Limited
Levin Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kunchala Srinivasarao Also directs: TSR Biosciences Private Limited | Director | 14 Jun 2019 | 7 Years 3 Months | Current |
| Anasuya Kunchala | Director | 14 Jun 2019 | 7 Years 3 Months | Current |
| Praveen Kumar Perumandla | Director | 14 Jun 2019 | 7 Years 3 Months | Current |
Ownership and Shareholding of Levin Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Levin Formulations Private Limited
Levin Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Levin Formulations Private Limited
Levin Formulations operates one associated brand: Levin Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of chronic segment pharmaceutical products by Levin Formulations. | levinformulations.com |
Employees and EPFO Compliance at Levin Formulations Private Limited
Levin Formulations Private Limited has a workforce of 20 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Levin Formulations Private Limited
Levin Formulations Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Harsha Vardhan Bodepudi ceased to be Director on 31 Mar 2021.
Credit Ratings, Litigation & Regulatory Alerts for Levin Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Levin Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Levin Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Levin Formulations Private Limited
Levin Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCL9559K1ZU | Telangana | Active | 16 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Levin Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Levin Formulations Private Limited
Levin Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2019 (7+ years old) and is registered under CIN U24100TG2019PTC133420.
Levin Formulations reported revenue of ₹2.36 Cr for FY 2025 (down 13% YoY).
Levin Formulations has 3 current directors:
- Kunchala Srinivasarao - Director
- Anasuya Kunchala - Director
- Praveen Kumar Perumandla - Director
Levin Formulations reported a net loss of ₹67.94 Lakh (net margin -28.7%) and EBITDA of -₹44.05 Lakh (EBITDA margin -18.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Levin Formulations is -5% over three years and 38% over five years. In the latest year (FY 2025) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Levin Formulations is 36AADCL9559K1ZU, registered in Telangana.
The CIN (Corporate Identification Number) of Levin Formulations is U24100TG2019PTC133420. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Levin Formulations was incorporated on 14 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Levin Formulations by revenue are Inovin Pharmaceuticals Private Limited, Abhiru Industries Limited, Supraceuticals Private Limited, Apricot Labs Private Limited, Bull Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Harsha Vardhan Bodepudi ceased to be Director on 31 Mar 2021. Anasuya Kunchala was appointed as Director on 14 Jun 2019. Kunchala Srinivasarao was appointed as Director on 14 Jun 2019. Levin Formulations has 4 board changes on record in total.
Levin Formulations can be reached through the website levinformulations.com. Its registered office is in Hyderabad, Telangana, India.